<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> is an important correlate of cardiometabolic risk, yet its association after the diagnosis of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> remains unclear </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Our objective was to assess the independent and combined associations of visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> to cardiometabolic risk </plain></SENT>
<SENT sid="2" pm="."><plain>The INternational Study of Prediction of Intra-abdominal <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> and its RElationships with cardioMEtabolic risk/Intra-Abdominal <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">Adiposity</z:e> (INSPIRE ME <z:mp ids='MP_0004157'>IAA</z:mp>) is a cross-sectional computed tomography imaging study with data collected from June 2006 to May 2008 </plain></SENT>
<SENT sid="3" pm="."><plain>General physicians, cardiologists, and diabetologists (n = 297) in 29 countries recruited 4144 (51.8% men) men (39-71 yr) and women (44-71 yr) </plain></SENT>
<SENT sid="4" pm="."><plain>Patients were categorized according to visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> tertiles, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> status, and sex </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> results were adjusted for age, body mass index, region, and physician's specialty </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Markers of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, <z:chebi fb="23" ids="18059">lipid</z:chebi>/<z:chebi fb="2" ids="6495">lipoproteins</z:chebi>, inflammatory markers, and liver fat increased with visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> in men and women with and without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Prevalent <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> increased with visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> tertiles, regardless of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> status </plain></SENT>
<SENT sid="8" pm="."><plain>Visceral <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> [odds ratio = 1.25 (1.09-1.44) for men and 1.78 (1.50-2.12) for women] was positively associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, whereas liver attenuation (inversely related to liver fat) was negatively associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> [odds ratio = 0.66 (0.59-0.75) for men and 0.63 (0.55-0.72) for women] </plain></SENT>
<SENT sid="9" pm="."><plain>Subcutaneous adipose tissue was inversely related to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in women [0.76 (0.0.66-0.88)] and not associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in men [0.97 (0.85-1.11)] </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Visceral, but not sc, abdominal <z:e sem="disease" ids="C0028754" disease_type="Disease or Syndrome" abbrv="">adiposity</z:e> is strongly related to cardiometabolic risk factors and to the prevalence of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> and may be an important driver of cardiometabolic risk in patients regardless of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> status </plain></SENT>
</text></document>